CellPly s.r.l

Cellply develops an innovative in-vitro diagnostic system to predict the efficacy of anticancer drugs with a personalized test that analyzes the in-vitro drug response of living cells quickly obtained from patient biopsies. The Gaetano Marzotto prize, at its 8th edition, aims at looking for new business people and builders of the future who are able to combine innovation, business and social impact.